whats not to like15 Jun 2020 11:15
Investors that invested at 120 will see this as opportunity to add even more to what they realise is a great opportunity in BILLION dollar cancer therapy market, that has the ULTIMATE disruptive delivery system for Chemotherapy drugs, and has made headline progress .
THe current market is fickle and is because of a band of ambulance chasers hot on the heals of a Covid 19 play and a 100% profit - without realising that they have stumbled upon a company that will ultimately be worth many multiples of where we are - On the cancer thereapies alone.
GLTA